Aitiologic
A precision-medicine company developing liquid-biopsy tests that interpret cell-free DNA signals for early disease risk assessment.
€6.4MSeed
LeadAI
Ananda Impact Ventures
Activity from announced rounds
Activity in this selectionEurope · Seed
- Rounds participated in
- 2
- Confirmed lead rounds
- 2 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $13.2M 2 disclosed · full round size, not this investor’s share